Lymphocytes decreased in mouse pneumonia model. by Qi Xu (134661)

CCCP decreased TMRE signals in <i>ex vivo</i> perfused hearts. by Akira Kawamoto (444329)

“…(B) Representative images of TMRE signals. Scale bar: 50μm. (C) CCCP decreased the TMRE signals of perfused hearts in a dose-dependent manner 20 min after CCCP perfusion (n = 3–4 per group). …”

Tax expression is associated with decreased cellular motility. by Saumya Ramanayake (7879091)

Subjects:

Bioluminescence decreased following <i>ex vivo</i> collagenase digestion of transgenic femora. by Sarah E. Mailhiot (766685)

“…<p>Femora from tamoxifen treated transgenic mice were degraded in collagenase. (A) The femur showed a linear decrease (r = -0.619, p = 0.0452) after 6 hours in digestion. …”

Diclofenac decreases angiogenesis. by Nina Mayorek (241888)

Variable importance plot (mean decrease accuracy and mean decrease Gini). by Fernando Martinez-Taboada (8655132)

The distributions of the end-simulation adolescence-limited proportion when (a) <i>k</i> is increased or decreased by 50%, (b) <i>c</i> is increased or decreased by 50%, (c) <i>γ</i> is increased or decreased by 50%, and (d) Δ<i>e</i> is increased or decreased by 50%, compared against the benchmark distribution <i>F</i>(<b>p</b>₀) for the parameters shown in Table 1. by Jia Ning Leaw (752775)

Elevated IDO activity in HD mouse brains is decreased by <i>ex-vivo</i> iron chelation. by David W. Donley (3111198)

“…<p>Mouse pups were supplemented with carbonyl iron from postnatal days 10–17 and then were sacrificed at 14 weeks of age. <b>A.</b> Striatal IDO activity is increased in N171-82Q HD mice and significantly decreased by <i>ex vivo</i> iron (III) chelation (50 μM deferoxamine). …”

Decreased knee bioluminescence was found with increased duration in an <i>in vivo</i> deterioration model. by Sarah E. Mailhiot (766685)

Expression of ApoB-50 decreased lipid accumulation and inhibited HCV production. by Bei Wang (116772)

NFκB-p50 knockdown decreases CD44 expression. by Shannon M. Smith (115335)

Damsin (D) and ambrosin (A) treatment decreases the CSC population. by Wendy Soria Sotillo (4408105)

LPS decreases only T cell proliferative response to OKT3. by Fanny Poujol (834338)

HFD decreases nephrocyte uptake of dextran and albumin. by Aleksandra Lubojemska (10746241)

<i>roh</i> mutation results in Rh1 decrease. by Yu Huang (15093)

“…<p>(A) GFP fluorescence of one-day old wild-type (left panel) and <i>roh</i>^{<i>EY04039</i>} (right panel) flies showing a reduction in Rh1-GFP. …”

Prevalence and anatomic level of stenosis ≥ 50% in either limb. by O. Stivalet (6890189)

EC50 and percentage decrease in intracellular <i>Listeria</i> viability for effective compounds. by Marie-Eve Charbonneau (5658799)

Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”

DMB treatment decreased neuronal apoptosis in cerebral ischemia. by Huinan Zhang (849524)

Affinity analysis results (with a confidence level above 50%). by Marta R. Jabłońska (8491404)